NCT04584346View on ClinicalTrials.gov

Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD)

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 21, 2021

Primary Completion Date

October 13, 2021

Study Completion Date

October 13, 2021

Conditions
Parkinson's Disease
Interventions
DIETARY_SUPPLEMENT

Liquigen MCT oil

MCT oil is a nutritional supplement. The Ketogenic diet restricted carbohydrates to reach 80/5-10/10-15 (lipid:carb:protein daily energy) values

OTHER

Standard American Diet

Standard diet with macronutrient composition lipid 35%, protein 10-15%, carbohydrate 50-55%

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT04584346 - Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD) | Biotech Hunter | Biotech Hunter